Synthesis of peptidic toxins : access to an immense library of active peptides  (suitable for use in the development of new drugs and therapies)

Introduction

Toxins extracted from spiders, molluscs and snakes have enabled the pharmacological characterization of a large number of ionic channels. Although pharmacological understanding of ionic channels is still limited, the discovery of active agents could play a significant role in the understanding of the physiological function of potential new targets.

Within this context, Smartox is a business unit that specialises in the synthesis of bespoke peptidic toxins. These toxins demonstrate significant potential as a result of their action on Ionic channels and G-protein coupled receptors. Smartox works alongside research teams with a view to identifying and characterizing the interactions between ionic channels and toxins. Many of the resulting molecules can then form the basis of medications or therapies planned for future development. Visit http://www.smartox-biotech.com for more information